| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM3 HAUS8 MYH10 MYH11 AKAP5 HOOK3 DST MYLK MAP1A CLU SPTBN1 KTN1 CEP290 DIAPH1 MACF1 GOLGA8O SMAD4 GOLGA8N HSP90AB1 | 3.07e-08 | 1099 | 78 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | 1.68e-05 | 479 | 78 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.69e-05 | 308 | 78 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.35e-04 | 614 | 78 | 10 | GO:0140657 | |
| GeneOntologyMolecularFunction | tubulin binding | 2.64e-04 | 428 | 78 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.05e-04 | 37 | 78 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | tau protein binding | 7.71e-04 | 46 | 78 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 9.69e-04 | 12 | 78 | 2 | GO:0045503 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 1.24e-03 | 305 | 78 | 6 | GO:0019207 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 1.53e-03 | 15 | 78 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.68e-03 | 441 | 78 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.96e-03 | 227 | 78 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.07e-03 | 230 | 78 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.11e-03 | 339 | 78 | 6 | GO:0045296 | |
| GeneOntologyBiologicalProcess | microtubule-based process | HAUS8 HOOK3 DST MAP1A ATRX SPEF2 KTN1 CEP290 SPC25 DNAI2 DIAPH1 NAV1 TEKT1 MACF1 CFAP74 CNTLN GOLGA8O GOLGA8N | 1.11e-07 | 1058 | 81 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | HAUS8 HOOK3 DST MAP1A ATRX SPEF2 CEP290 SPC25 DNAI2 NAV1 CFAP74 CNTLN GOLGA8O GOLGA8N | 7.36e-07 | 720 | 81 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MYH10 AKAP5 DST SH3GLB1 MAP1A CLU DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 2.61e-06 | 802 | 81 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYH10 AKAP5 DST SH3GLB1 MAP1A CLU DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 3.33e-06 | 819 | 81 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYH10 AKAP5 DST SH3GLB1 MAP1A CLU DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 3.68e-06 | 826 | 81 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TPM3 HAUS8 MYH10 MYH11 HOOK3 MAP1A CLU SPTBN1 DIAPH1 ARHGAP25 GOLGA8O CIT SMAD4 GOLGA8N HSP90AB1 | 4.11e-06 | 957 | 81 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYH10 AKAP5 DST SH3GLB1 MAP1A DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 6.52e-06 | 748 | 81 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | organelle assembly | GMNC HAUS8 MYH10 MYH11 SH3GLB1 CEP162 SPEF2 CEP290 DNAI2 TEKT1 CFAP74 GOLGA8O SEPTIN6 SMAD4 GOLGA8N | 3.20e-05 | 1138 | 81 | 15 | GO:0070925 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | 5.96e-05 | 172 | 81 | 6 | GO:0098876 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH10 HOOK3 GOLGA8T SH3GLB1 CLU SPTBN1 REEP5 GOLGA8O CIT GOLGA8Q GOLGA8N | 6.18e-05 | 672 | 81 | 11 | GO:0010256 |
| GeneOntologyBiologicalProcess | axonogenesis | MYH10 DST MAP1A DIAPH1 MACF1 POU4F3 GOLGA8O GOLGA4 SMAD4 GOLGA8N | 7.30e-05 | 566 | 81 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | protein localization to organelle | AKAP5 HOOK3 SH3GLB1 MAP1A ATRX UACA CLU RABEP1 TAX1BP1 CIZ1 DIAPH1 MACF1 CNTLN HSP90AB1 | 8.13e-05 | 1091 | 81 | 14 | GO:0033365 |
| GeneOntologyBiologicalProcess | cell division | HAUS8 MYH10 CCDC124 SH3GLB1 SPTBN1 SPC25 GOLGA8O CIT TADA3 SEPTIN6 GOLGA8N | 8.55e-05 | 697 | 81 | 11 | GO:0051301 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular protein transport | 9.40e-05 | 116 | 81 | 5 | GO:0090316 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 1.06e-04 | 119 | 81 | 5 | GO:0006892 | |
| GeneOntologyBiologicalProcess | Golgi localization | 1.59e-04 | 27 | 81 | 3 | GO:0051645 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 1.66e-04 | 70 | 81 | 4 | GO:0006893 | |
| GeneOntologyBiologicalProcess | intracellular transport | CCDC91 MYH10 AKAP5 HOOK3 DST SH3GLB1 MAP1A UACA CLU CEP290 ASPH REEP5 GOLGA8O RSRC1 GOLGA8N HSP90AB1 | 2.01e-04 | 1496 | 81 | 16 | GO:0046907 |
| GeneOntologyBiologicalProcess | axon development | MYH10 DST MAP1A DIAPH1 MACF1 POU4F3 GOLGA8O GOLGA4 SMAD4 GOLGA8N | 2.04e-04 | 642 | 81 | 10 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYH10 AKAP5 DST SH3GLB1 MAP1A CLU DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 2.10e-04 | 1194 | 81 | 14 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of MHC class I biosynthetic process | 2.26e-04 | 6 | 81 | 2 | GO:0045345 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to plasma membrane | 2.28e-04 | 76 | 81 | 4 | GO:0061951 | |
| GeneOntologyBiologicalProcess | regulation of intracellular transport | 2.35e-04 | 314 | 81 | 7 | GO:0032386 | |
| GeneOntologyBiologicalProcess | regulation of DNA replication | 2.85e-04 | 147 | 81 | 5 | GO:0006275 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | GMNC MYH10 MYLK CEP162 SPEF2 CEP290 DNAI2 TEKT1 CFAP74 SEPTIN6 | 2.88e-04 | 670 | 81 | 10 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | GMNC MYH10 MYLK CEP162 SPEF2 CEP290 DNAI2 TEKT1 CFAP74 SEPTIN6 | 3.43e-04 | 685 | 81 | 10 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | 3.53e-04 | 444 | 81 | 8 | GO:0060271 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | 3.74e-04 | 339 | 81 | 7 | GO:0048193 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 4.12e-04 | 37 | 81 | 3 | GO:0000212 | |
| GeneOntologyBiologicalProcess | regulation of MHC class I biosynthetic process | 4.20e-04 | 8 | 81 | 2 | GO:0045343 | |
| GeneOntologyBiologicalProcess | MHC class I biosynthetic process | 4.20e-04 | 8 | 81 | 2 | GO:0045341 | |
| GeneOntologyBiologicalProcess | neuron projection development | MYH10 AKAP5 DST SH3GLB1 MAP1A CLU DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 4.43e-04 | 1285 | 81 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 4.45e-04 | 162 | 81 | 5 | GO:0032388 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 5.10e-04 | 591 | 81 | 9 | GO:1903829 | |
| GeneOntologyBiologicalProcess | neuron development | MYH10 AKAP5 DST SH3GLB1 MAP1A CLU CEP290 DIAPH1 MACF1 POU4F3 GOLGA8O CIT GOLGA4 SMAD4 GOLGA8N | 5.13e-04 | 1463 | 81 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | Golgi organization | 5.25e-04 | 168 | 81 | 5 | GO:0007030 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 5.36e-04 | 95 | 81 | 4 | GO:0000281 | |
| GeneOntologyBiologicalProcess | cilium organization | 5.59e-04 | 476 | 81 | 8 | GO:0044782 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 7.35e-04 | 45 | 81 | 3 | GO:0043001 | |
| GeneOntologyBiologicalProcess | regulation of intracellular protein transport | 7.54e-04 | 182 | 81 | 5 | GO:0033157 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 9.32e-04 | 515 | 81 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | cellular hypotonic response | 9.80e-04 | 12 | 81 | 2 | GO:0071476 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.04e-03 | 403 | 81 | 7 | GO:1904951 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.06e-03 | 114 | 81 | 4 | GO:0050772 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM3 CAB39 HAUS8 MYH10 MYH11 HOOK3 DST MAP1A CEP162 SPTBN1 DNAI2 DIAPH1 NAV1 TEKT1 MACF1 TMEM214 GOLGA8O GOLGA8N | 3.71e-07 | 1179 | 80 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM3 CAB39 HAUS8 MYH10 MYH11 HOOK3 DST MAP1A CEP162 SPTBN1 DNAI2 DIAPH1 NAV1 TEKT1 MACF1 TMEM214 GOLGA8O GOLGA8N | 4.10e-07 | 1187 | 80 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | HAUS8 HOOK3 DST MAP1A CEP162 DNAI2 NAV1 TEKT1 MACF1 TMEM214 GOLGA8O GOLGA8N | 8.31e-07 | 533 | 80 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | cleavage furrow | 3.64e-06 | 61 | 80 | 5 | GO:0032154 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM3 HAUS8 HOOK3 DST MAP1A CEP162 DNAI2 DIAPH1 NAV1 TEKT1 MACF1 TMEM214 GOLGA8O GOLGA8N | 7.17e-06 | 899 | 80 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | Golgi cis cisterna | 7.48e-06 | 33 | 80 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | cell division site | 1.39e-05 | 80 | 80 | 5 | GO:0032153 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.87e-05 | 85 | 80 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 5.67e-05 | 107 | 80 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 5.67e-05 | 107 | 80 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 8.67e-05 | 117 | 80 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 9.03e-05 | 118 | 80 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.70e-04 | 135 | 80 | 5 | GO:0031985 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 3.50e-04 | 576 | 80 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | spindle | 4.39e-04 | 471 | 80 | 8 | GO:0005819 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 4.67e-04 | 94 | 80 | 4 | GO:0032580 | |
| GeneOntologyCellularComponent | Golgi stack | 5.06e-04 | 171 | 80 | 5 | GO:0005795 | |
| GeneOntologyCellularComponent | cell cortex | 5.48e-04 | 371 | 80 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | cell leading edge | 6.50e-04 | 500 | 80 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | centrosome | HAUS8 FAM184A HOOK3 CCDC124 RBBP6 CEP162 CEP290 DIAPH1 CNTLN SMAD4 | 6.95e-04 | 770 | 80 | 10 | GO:0005813 |
| GeneOntologyCellularComponent | mitotic spindle | 1.05e-03 | 201 | 80 | 5 | GO:0072686 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.36e-03 | 317 | 80 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | distal axon | 1.39e-03 | 435 | 80 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | centriolar satellite | 1.48e-03 | 128 | 80 | 4 | GO:0034451 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.54e-03 | 443 | 80 | 7 | GO:0098791 | |
| GeneOntologyCellularComponent | midbody | 1.63e-03 | 222 | 80 | 5 | GO:0030496 | |
| GeneOntologyCellularComponent | axon | 2.08e-03 | 891 | 80 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.58e-03 | 360 | 80 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | microtubule organizing center | HAUS8 FAM184A HOOK3 CCDC124 RBBP6 CEP162 CEP290 DIAPH1 CNTLN SMAD4 | 2.60e-03 | 919 | 80 | 10 | GO:0005815 |
| GeneOntologyCellularComponent | dynein axonemal particle | 2.63e-03 | 20 | 80 | 2 | GO:0120293 | |
| GeneOntologyCellularComponent | brush border | 2.77e-03 | 152 | 80 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | myosin filament | 4.10e-03 | 25 | 80 | 2 | GO:0032982 | |
| GeneOntologyCellularComponent | main axon | 4.84e-03 | 89 | 80 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.12e-03 | 290 | 80 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | myosin II complex | 5.13e-03 | 28 | 80 | 2 | GO:0016460 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 5.49e-03 | 29 | 80 | 2 | GO:0097038 | |
| GeneOntologyCellularComponent | axon initial segment | 5.49e-03 | 29 | 80 | 2 | GO:0043194 | |
| HumanPheno | Pregnancy history | 7.17e-06 | 182 | 22 | 7 | HP:0002686 | |
| HumanPheno | Past medical history | 7.43e-06 | 183 | 22 | 7 | HP:0032443 | |
| HumanPheno | Abnormal sputum | 1.70e-05 | 136 | 22 | 6 | HP:0032016 | |
| HumanPheno | Triangular nasal tip | 1.78e-05 | 2 | 22 | 2 | HP:0000451 | |
| HumanPheno | Long fingers | 2.36e-05 | 306 | 22 | 8 | HP:0100807 | |
| HumanPheno | Intestinal malrotation | 3.86e-05 | 157 | 22 | 6 | HP:0002566 | |
| HumanPheno | Slender finger | 4.15e-05 | 159 | 22 | 6 | HP:0001238 | |
| HumanPheno | Hypertelorism | TPM3 MYH11 MYLK ATRX SPTBN1 CEP290 ZMYM2 MACF1 CIT LETM1 RSRC1 SMAD4 | 4.27e-05 | 830 | 22 | 12 | HP:0000316 |
| HumanPheno | Supernumerary spleens | 5.59e-05 | 101 | 22 | 5 | HP:0009799 | |
| HumanPheno | Dilatation of the cerebral artery | 5.71e-05 | 51 | 22 | 4 | HP:0004944 | |
| HumanPheno | Mucoid extracellular matrix accumulation | 6.48e-05 | 19 | 22 | 3 | HP:0200146 | |
| HumanPheno | Medial degeneration | 6.48e-05 | 19 | 22 | 3 | HP:0032079 | |
| HumanPheno | Cystic medial necrosis | 6.48e-05 | 19 | 22 | 3 | HP:0012180 | |
| HumanPheno | Descending thoracic aorta aneurysm | 6.48e-05 | 19 | 22 | 3 | HP:0004959 | |
| HumanPheno | Abnormal finger morphology | TPM3 TCF4 MYH11 MYLK ATRX CIITA SPEF2 SPTBN1 CEP290 ASPH DNAI2 ZMYM2 CFAP74 LETM1 SMAD4 | 6.94e-05 | 1385 | 22 | 15 | HP:0001167 |
| HumanPheno | Paroxysmal dyspnea | 7.60e-05 | 20 | 22 | 3 | HP:0012763 | |
| HumanPheno | Descending aortic dissection | 8.84e-05 | 21 | 22 | 3 | HP:0012499 | |
| HumanPheno | Rhinitis | 9.58e-05 | 113 | 22 | 5 | HP:0012384 | |
| HumanPheno | Fetal megacystis | 1.06e-04 | 4 | 22 | 2 | HP:0010956 | |
| HumanPheno | Abnormality of globe location or size | TPM3 TCF4 MYH11 MYLK ATRX SPTBN1 CEP290 ASPH ZMYM2 MACF1 CIT LETM1 RSRC1 SMAD4 | 1.08e-04 | 1246 | 22 | 14 | HP:0000489 |
| HumanPheno | Dural ectasia | 1.33e-04 | 24 | 22 | 3 | HP:0100775 | |
| HumanPheno | Carotid artery dilatation | 1.33e-04 | 24 | 22 | 3 | HP:0012163 | |
| HumanPheno | Abnormal cardiac ventricle morphology | TPM3 MYH11 DST MYLK ATRX SPTBN1 CEP290 ZMYM2 MACF1 LETM1 SMAD4 | 1.41e-04 | 780 | 22 | 11 | HP:0001713 |
| HumanPheno | Abnormal spinal meningeal morphology | 1.51e-04 | 25 | 22 | 3 | HP:0010303 | |
| HumanPheno | High palate | TPM3 MYH11 DST MYLK ATRX SPTBN1 CEP290 ASPH ZMYM2 LETM1 SMAD4 | 1.66e-04 | 794 | 22 | 11 | HP:0000218 |
| HumanPheno | Ascending aortic dissection | 1.71e-04 | 26 | 22 | 3 | HP:0004933 | |
| HumanPheno | Abnormality of globe location | TPM3 TCF4 MYH11 MYLK ATRX SPTBN1 CEP290 ZMYM2 MACF1 CIT LETM1 RSRC1 SMAD4 | 1.78e-04 | 1122 | 22 | 13 | HP:0100886 |
| HumanPheno | Abnormal ascending aorta morphology | 1.91e-04 | 27 | 22 | 3 | HP:0031784 | |
| HumanPheno | Aortic root aneurysm | 1.98e-04 | 70 | 22 | 4 | HP:0002616 | |
| HumanPheno | Arachnodactyly | 2.07e-04 | 133 | 22 | 5 | HP:0001166 | |
| HumanPheno | Abdominal situs inversus | 2.82e-04 | 142 | 22 | 5 | HP:0003363 | |
| HumanPheno | Situs inversus totalis | 2.82e-04 | 142 | 22 | 5 | HP:0001696 | |
| HumanPheno | Abnormal spatial orientation of the cardiac segments | 2.82e-04 | 142 | 22 | 5 | HP:0011534 | |
| HumanPheno | Abnormality of abdominal situs | 2.82e-04 | 142 | 22 | 5 | HP:0011620 | |
| HumanPheno | Heterotaxy | 3.11e-04 | 145 | 22 | 5 | HP:0030853 | |
| HumanPheno | Abnormality of blood volume homeostasis | 3.20e-04 | 32 | 22 | 3 | HP:0011104 | |
| HumanPheno | Hypovolemia | 3.20e-04 | 32 | 22 | 3 | HP:0011106 | |
| HumanPheno | Abnormal nasal mucosa morphology | 3.33e-04 | 80 | 22 | 4 | HP:0000433 | |
| HumanPheno | Peripheral arterial stenosis | 3.51e-04 | 33 | 22 | 3 | HP:0004950 | |
| HumanPheno | Clubbing | 3.87e-04 | 152 | 22 | 5 | HP:0001217 | |
| HumanPheno | Dilatation of the ascending aorta | 4.01e-04 | 84 | 22 | 4 | HP:0005111 | |
| HumanPheno | High, narrow palate | 4.36e-04 | 156 | 22 | 5 | HP:0002705 | |
| HumanPheno | Abnormality of the bronchi | 4.63e-04 | 246 | 22 | 6 | HP:0002109 | |
| HumanPheno | Dextrocardia | 4.76e-04 | 159 | 22 | 5 | HP:0001651 | |
| HumanPheno | Abnormal anatomic location of the heart | 4.90e-04 | 160 | 22 | 5 | HP:0004307 | |
| HumanPheno | Ischemic stroke | 5.35e-04 | 38 | 22 | 3 | HP:0002140 | |
| HumanPheno | Asplenia | 5.45e-04 | 91 | 22 | 4 | HP:0001746 | |
| HumanPheno | Subarachnoid hemorrhage | 5.78e-04 | 39 | 22 | 3 | HP:0002138 | |
| HumanPheno | Cerebral infarct | 5.78e-04 | 39 | 22 | 3 | HP:0025722 | |
| HumanPheno | Otitis media | 5.88e-04 | 363 | 22 | 7 | HP:0000388 | |
| HumanPheno | Pes planus | 6.08e-04 | 365 | 22 | 7 | HP:0001763 | |
| HumanPheno | Long toe | 6.14e-04 | 168 | 22 | 5 | HP:0010511 | |
| HumanPheno | Aortic dilatation | 6.14e-04 | 168 | 22 | 5 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 6.14e-04 | 168 | 22 | 5 | HP:0004942 | |
| HumanPheno | Aortic dissection | 6.23e-04 | 40 | 22 | 3 | HP:0002647 | |
| HumanPheno | Abnormal intestine morphology | TCF4 MYH11 MYLK ATRX CIITA SPEF2 SPTBN1 CEP290 DNAI2 ZMYM2 CFAP74 LETM1 RSRC1 SMAD4 | 6.58e-04 | 1459 | 22 | 14 | HP:0002242 |
| HumanPheno | Aplasia/Hypoplasia of the spleen | 7.22e-04 | 98 | 22 | 4 | HP:0010451 | |
| HumanPheno | Abnormality of the lower urinary tract | MYH11 MYLK ATRX SPTBN1 CEP290 ZMYM2 MACF1 CIT LETM1 RSRC1 SMAD4 | 7.46e-04 | 937 | 22 | 11 | HP:0010936 |
| HumanPheno | Abnormality of the upper respiratory tract | TPM3 MYH11 DST ATRX CIITA SPEF2 SPTBN1 DNAI2 CIZ1 DIAPH1 CFAP74 SMAD4 | 7.84e-04 | 1111 | 22 | 12 | HP:0002087 |
| HumanPheno | Microcolon | 7.85e-04 | 10 | 22 | 2 | HP:0004388 | |
| HumanPheno | Megacystis | 7.85e-04 | 10 | 22 | 2 | HP:0000021 | |
| HumanPheno | Ventricular septal defect | 8.58e-04 | 510 | 22 | 8 | HP:0001629 | |
| HumanPheno | Aortic regurgitation | 8.71e-04 | 103 | 22 | 4 | HP:0001659 | |
| HumanPheno | Abnormal middle ear morphology | 9.07e-04 | 390 | 22 | 7 | HP:0008609 | |
| HumanPheno | Motor stereotypy | 9.23e-04 | 280 | 22 | 6 | HP:0000733 | |
| HumanPheno | Abnormal vascular morphology | TPM3 TCF4 MYH11 MYLK ATRX CIITA SPEF2 SPTBN1 DNAI2 DIAPH1 ZMYM2 CFAP74 SMAD4 | 9.79e-04 | 1319 | 22 | 13 | HP:0025015 |
| HumanPheno | Abnormal ventricular septum morphology | 9.89e-04 | 521 | 22 | 8 | HP:0010438 | |
| HumanPheno | Abnormal paranasal sinus morphology | 1.05e-03 | 189 | 22 | 5 | HP:0000245 | |
| HumanPheno | Peribronchovascular interstitial thickening | 1.13e-03 | 49 | 22 | 3 | HP:0025177 | |
| HumanPheno | Ectopic pregnancy | 1.13e-03 | 49 | 22 | 3 | HP:0031456 | |
| HumanPheno | Pulmonary situs ambiguus | 1.13e-03 | 49 | 22 | 3 | HP:0011617 | |
| HumanPheno | Abnormal pulmonary situs morphology | 1.13e-03 | 49 | 22 | 3 | HP:0011615 | |
| HumanPheno | Lithoptysis | 1.13e-03 | 49 | 22 | 3 | HP:0032543 | |
| HumanPheno | Dilatation of the bladder | 1.14e-03 | 12 | 22 | 2 | HP:0010955 | |
| HumanPheno | Abnormality of prenatal development or birth | TPM3 TCF4 MYH11 DST MYLK SPEF2 SPTBN1 CEP290 DNAI2 CFAP74 LETM1 SMAD4 | 1.17e-03 | 1159 | 22 | 12 | HP:0001197 |
| HumanPheno | Atrial situs ambiguous | 1.20e-03 | 50 | 22 | 3 | HP:0011539 | |
| HumanPheno | Abnormal tracheobronchial morphology | 1.22e-03 | 410 | 22 | 7 | HP:0005607 | |
| HumanPheno | Poor appetite | 1.27e-03 | 51 | 22 | 3 | HP:0004396 | |
| HumanPheno | Protracted diarrhea | 1.35e-03 | 13 | 22 | 2 | HP:0004385 | |
| HumanPheno | Short upper lip | 1.35e-03 | 13 | 22 | 2 | HP:0000188 | |
| HumanPheno | Narrow palate | 1.41e-03 | 202 | 22 | 5 | HP:0000189 | |
| HumanPheno | Abnormal inferior vena cava morphology | 1.42e-03 | 53 | 22 | 3 | HP:0025576 | |
| HumanPheno | Abnormal fingertip morphology | 1.45e-03 | 203 | 22 | 5 | HP:0001211 | |
| HumanPheno | Bicuspid aortic valve | 1.50e-03 | 119 | 22 | 4 | HP:0001647 | |
| HumanPheno | Abnormal atrial arrangement | 1.50e-03 | 54 | 22 | 3 | HP:0011535 | |
| HumanPheno | Aplasia/Hypoplasia of the colon | 1.57e-03 | 14 | 22 | 2 | HP:0100811 | |
| HumanPheno | Thoracic aortic aneurysm | 1.59e-03 | 121 | 22 | 4 | HP:0012727 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 1.59e-03 | 121 | 22 | 4 | HP:0031567 | |
| HumanPheno | Abnormal blood vessel morphology | TPM3 TCF4 MYH11 MYLK ATRX CIITA SPEF2 SPTBN1 DNAI2 ZMYM2 CFAP74 SMAD4 | 1.64e-03 | 1201 | 22 | 12 | HP:0033353 |
| HumanPheno | Abnormal palate morphology | TPM3 TCF4 MYH11 DST MYLK ATRX SPTBN1 CEP290 ASPH ZMYM2 LETM1 SMAD4 | 1.65e-03 | 1202 | 22 | 12 | HP:0000174 |
| HumanPheno | Recurrent infections | TPM3 TCF4 MYH11 ATRX CIITA SPEF2 SPTBN1 DNAI2 DIAPH1 CFAP74 LETM1 | 1.70e-03 | 1030 | 22 | 11 | HP:0002719 |
| HumanPheno | Abdominal aortic aneurysm | 1.79e-03 | 125 | 22 | 4 | HP:0005112 | |
| HumanPheno | Neoplasm of the heart | 1.81e-03 | 15 | 22 | 2 | HP:0100544 | |
| HumanPheno | Abnormal pattern of respiration | 1.83e-03 | 872 | 22 | 10 | HP:0002793 | |
| HumanPheno | Vascular dilatation | 1.87e-03 | 215 | 22 | 5 | HP:0002617 | |
| HumanPheno | Abnormal bronchus morphology | 1.87e-03 | 215 | 22 | 5 | HP:0025426 | |
| HumanPheno | Nasal congestion | 2.04e-03 | 60 | 22 | 3 | HP:0001742 | |
| HumanPheno | Talipes | 2.08e-03 | 583 | 22 | 8 | HP:0001883 | |
| MousePheno | slow postnatal weight gain | 3.63e-05 | 205 | 63 | 7 | MP:0008489 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 5.69e-05 | 220 | 63 | 7 | MP:0000875 | |
| MousePheno | abnormal cerebellar cortex morphology | 5.70e-05 | 300 | 63 | 8 | MP:0004097 | |
| MousePheno | abnormal metencephalon morphology | 1.03e-04 | 420 | 63 | 9 | MP:0000847 | |
| MousePheno | abnormal motor coordination/balance | TCF4 MYH10 AKAP5 DST MAP1A CIZ1 NCOA1 POU4F3 PLCL1 GOLGA8O CIT IMMT GOLGA8N | 1.14e-04 | 873 | 63 | 13 | MP:0001516 |
| MousePheno | absent coronary vessels | 1.19e-04 | 4 | 63 | 2 | MP:0010561 | |
| MousePheno | abnormal cerebellar layer morphology | 1.73e-04 | 263 | 63 | 7 | MP:0009956 | |
| Domain | Mo25 | 1.55e-05 | 2 | 74 | 2 | IPR013878 | |
| Domain | Mo25 | 1.55e-05 | 2 | 74 | 2 | PF08569 | |
| Domain | Actinin_actin-bd_CS | 9.99e-05 | 23 | 74 | 3 | IPR001589 | |
| Domain | Spectrin | 9.99e-05 | 23 | 74 | 3 | PF00435 | |
| Domain | ACTININ_2 | 9.99e-05 | 23 | 74 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.99e-05 | 23 | 74 | 3 | PS00019 | |
| Domain | Myosin_S1_N | 1.54e-04 | 5 | 74 | 2 | IPR008989 | |
| Domain | CH | 2.01e-04 | 73 | 74 | 4 | PS50021 | |
| Domain | Spectrin_repeat | 2.03e-04 | 29 | 74 | 3 | IPR002017 | |
| Domain | CH-domain | 2.23e-04 | 75 | 74 | 4 | IPR001715 | |
| Domain | DDT | 2.30e-04 | 6 | 74 | 2 | PS50827 | |
| Domain | - | 2.30e-04 | 6 | 74 | 2 | 3.90.1290.10 | |
| Domain | GAR | 2.30e-04 | 6 | 74 | 2 | PS51460 | |
| Domain | - | 2.30e-04 | 6 | 74 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 2.30e-04 | 6 | 74 | 2 | IPR003108 | |
| Domain | GAS2 | 2.30e-04 | 6 | 74 | 2 | PF02187 | |
| Domain | GAS2 | 2.30e-04 | 6 | 74 | 2 | SM00243 | |
| Domain | Spectrin/alpha-actinin | 2.73e-04 | 32 | 74 | 3 | IPR018159 | |
| Domain | SPEC | 2.73e-04 | 32 | 74 | 3 | SM00150 | |
| Domain | Plectin_repeat | 3.21e-04 | 7 | 74 | 2 | IPR001101 | |
| Domain | Plectin | 3.21e-04 | 7 | 74 | 2 | PF00681 | |
| Domain | PLEC | 3.21e-04 | 7 | 74 | 2 | SM00250 | |
| Domain | PH_dom-spectrin-type | 5.48e-04 | 9 | 74 | 2 | IPR001605 | |
| Domain | Znf_C2H2_matrin | 9.96e-04 | 12 | 74 | 2 | IPR000690 | |
| Domain | Myosin_N | 1.57e-03 | 15 | 74 | 2 | PF02736 | |
| Domain | Myosin_N | 1.57e-03 | 15 | 74 | 2 | IPR004009 | |
| Domain | P-loop_NTPase | NLRP9 MYH10 MYH11 LRRIQ1 ATRX CIITA SPEF2 NAV1 CHD1L SEPTIN6 | 1.82e-03 | 848 | 74 | 10 | IPR027417 |
| Domain | CH | 2.19e-03 | 65 | 74 | 3 | SM00033 | |
| Domain | GOLGA2L5 | 2.27e-03 | 18 | 74 | 2 | PF15070 | |
| Domain | Golgin_A | 2.27e-03 | 18 | 74 | 2 | IPR024858 | |
| Domain | Myosin_tail_1 | 2.27e-03 | 18 | 74 | 2 | PF01576 | |
| Domain | Myosin_tail | 2.27e-03 | 18 | 74 | 2 | IPR002928 | |
| Domain | ZF_MATRIN | 2.27e-03 | 18 | 74 | 2 | PS50171 | |
| Domain | HATPase_c | 2.27e-03 | 18 | 74 | 2 | SM00387 | |
| Domain | HATPase_c | 2.54e-03 | 19 | 74 | 2 | PF02518 | |
| Domain | Myosin-like_IQ_dom | 2.54e-03 | 19 | 74 | 2 | IPR027401 | |
| Domain | - | 2.54e-03 | 19 | 74 | 2 | 4.10.270.10 | |
| Domain | CH | 2.70e-03 | 70 | 74 | 3 | PF00307 | |
| Domain | - | 2.81e-03 | 20 | 74 | 2 | 3.30.565.10 | |
| Domain | IQ | 2.81e-03 | 71 | 74 | 3 | PF00612 | |
| Domain | - | 2.81e-03 | 71 | 74 | 3 | 1.10.418.10 | |
| Domain | HATPase_C | 3.10e-03 | 21 | 74 | 2 | IPR003594 | |
| Domain | NACHT | 3.71e-03 | 23 | 74 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 3.71e-03 | 23 | 74 | 2 | IPR007111 | |
| Domain | Znf_PHD-finger | 3.81e-03 | 79 | 74 | 3 | IPR019787 | |
| Domain | IQ | 4.08e-03 | 81 | 74 | 3 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 5.48e-03 | 90 | 74 | 3 | IPR000048 | |
| Domain | EF-hand-dom_pair | 5.62e-03 | 287 | 74 | 5 | IPR011992 | |
| Domain | ZnF_U1 | 5.87e-03 | 29 | 74 | 2 | SM00451 | |
| Domain | Znf_U1 | 5.87e-03 | 29 | 74 | 2 | IPR003604 | |
| Domain | IQ | 6.00e-03 | 93 | 74 | 3 | PS50096 | |
| Domain | ZF_PHD_2 | 6.37e-03 | 95 | 74 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 6.55e-03 | 96 | 74 | 3 | PS01359 | |
| Domain | SNF2_N | 7.11e-03 | 32 | 74 | 2 | IPR000330 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM3 MYH10 MYH11 DST MYLK RBBP6 SPTBN1 KTN1 SPC25 DIAPH1 ARHGAP25 GIT2 GOLGA8O LETM1 GOLGA8N HSP90AB1 | 9.92e-09 | 649 | 61 | 16 | MM15690 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM3 MYH10 MYH11 DST MYLK UACA RBBP6 SPTBN1 KTN1 SPC25 DIAPH1 ARHGAP25 GIT2 CIT LETM1 HSP90AB1 | 4.26e-08 | 720 | 61 | 16 | M41838 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TPM3 DST RBBP6 SPTBN1 KTN1 DIAPH1 ARHGAP25 GIT2 GOLGA8O LETM1 GOLGA8N HSP90AB1 | 3.13e-07 | 439 | 61 | 12 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TPM3 DST UACA RBBP6 SPTBN1 KTN1 DIAPH1 ARHGAP25 GIT2 CIT LETM1 HSP90AB1 | 4.07e-07 | 450 | 61 | 12 | M27078 |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 1.88e-05 | 37 | 61 | 4 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 1.88e-05 | 37 | 61 | 4 | MM15610 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 7.11e-05 | 19 | 61 | 3 | M27489 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 9.70e-05 | 21 | 61 | 3 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.28e-04 | 23 | 61 | 3 | MM15222 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 4.57e-04 | 35 | 61 | 3 | MM15114 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 4.69e-04 | 323 | 61 | 7 | M27080 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 6.31e-04 | 39 | 61 | 3 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 6.80e-04 | 40 | 61 | 3 | M41816 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 8.31e-04 | 257 | 61 | 6 | MM14755 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 8.41e-04 | 43 | 61 | 3 | M1429 | |
| Pubmed | MYH10 HOOK3 CCDC124 DST UACA CLU RABEP1 SPTBN1 KTN1 TAX1BP1 DIAPH1 MIOS NAV1 ZMYM2 MACF1 PLCL1 GIT2 GOLGA8O CIT LETM1 GOLGA4 GOLGA8N HSP90AB1 | 2.40e-17 | 963 | 81 | 23 | 28671696 | |
| Pubmed | TPM3 CAB39 HOOK3 DST SH3GLB1 UACA RABEP1 SPTBN1 KTN1 TAX1BP1 MACF1 GIT2 SMAD4 HSP90AB1 | 9.40e-12 | 497 | 81 | 14 | 23414517 | |
| Pubmed | TPM3 FAM184A CCDC124 DST ATRX UACA RBBP6 KTN1 ASPH NFRKB RBM26 NFX1 CIZ1 MIOS ZMYM2 MACF1 TMEM214 CIT TADA3 IMMT RSRC1 | 2.05e-11 | 1497 | 81 | 21 | 31527615 | |
| Pubmed | TPM3 MYH10 CCDC124 DST ATRX SPTBN1 KTN1 DIAPH1 MACF1 CAB39L CHD1L SEPTIN6 RSRC1 HSP90AB1 | 2.68e-11 | 538 | 81 | 14 | 28524877 | |
| Pubmed | TPM3 CAB39 MYH10 MYH11 DST MAP1A CLU PDK1 SPTBN1 KTN1 MIOS NAV1 MACF1 PLCL1 REEP5 CIT IMMT LETM1 SEPTIN6 HSP90AB1 | 7.25e-11 | 1431 | 81 | 20 | 37142655 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.13e-10 | 120 | 81 | 8 | 31413325 | |
| Pubmed | MYH10 MYH11 DST MAP1A RBBP6 SPTBN1 KTN1 CEP290 NAV1 ZMYM2 MACF1 HSP90AB1 | 1.43e-09 | 486 | 81 | 12 | 20936779 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM3 MYH10 CCDC124 DST MAP1A ATRX RBBP6 RABEP1 KTN1 RSF1 RBM26 CIZ1 ZMYM2 MACF1 HSP90AB1 | 3.81e-09 | 934 | 81 | 15 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CCDC124 ATRX RBBP6 BAZ2B KTN1 WBP4 RSF1 NFRKB RBM26 CIZ1 ZMYM2 POU4F3 TADA3 IMMT HSP90AB1 | 5.06e-09 | 954 | 81 | 15 | 36373674 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM3 MYH10 URI1 CCDC124 SPTBN1 KTN1 ASPH SPC25 RBM26 DIAPH1 NAV1 MACF1 IMMT LETM1 GOLGA4 RSRC1 HSP90AB1 | 2.27e-08 | 1415 | 81 | 17 | 28515276 |
| Pubmed | MIPOL1 TPM3 MYH10 MYH11 AKAP5 DST MYLK ATRX SPEF2 SPTBN1 KTN1 RSF1 MACF1 CFAP74 IMMT LETM1 HSP90AB1 | 2.99e-08 | 1442 | 81 | 17 | 35575683 | |
| Pubmed | HAUS8 PDK1 WBP4 ASPH RBM26 DIAPH1 ZMYM2 TMEM214 IMMT LETM1 HSP90AB1 | 7.50e-08 | 560 | 81 | 11 | 35241646 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | TPM3 CAB39 MYH10 MAP1A RABEP1 SPTBN1 CEP290 ASPH GOLGA4 RSRC1 HSP90AB1 | 8.06e-08 | 564 | 81 | 11 | 21565611 |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 1.21e-07 | 5 | 81 | 3 | 11121372 | |
| Pubmed | HAUS8 KTN1 WBP4 CEP290 SPC25 NFRKB RBM26 DIAPH1 MIOS NAV1 REEP5 GOLGA4 | 1.32e-07 | 733 | 81 | 12 | 34672954 | |
| Pubmed | TPM3 PTMS TCF4 MYH10 DST ATRX RBBP6 SPTBN1 NFRKB ZMYM2 NCOA1 CIT TADA3 IMMT SEPTIN6 RSRC1 | 1.64e-07 | 1429 | 81 | 16 | 35140242 | |
| Pubmed | 1.75e-07 | 54 | 81 | 5 | 22266860 | ||
| Pubmed | MYH11 SH3GLB1 UACA BAZ2B KTN1 CEP290 MACF1 ARHGAP25 KAZN SEPTIN6 | 2.29e-07 | 493 | 81 | 10 | 15368895 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DST ATRX RBBP6 BAZ2B KTN1 CEP290 ASPH NFRKB CIZ1 ZMYM2 TMEM214 CHD1L TADA3 RSRC1 SMAD4 | 2.72e-07 | 1294 | 81 | 15 | 30804502 |
| Pubmed | FAM184A AKAP5 ATRX UACA CLU PDK1 SPTBN1 KTN1 ASPH CIZ1 MACF1 TMEM214 TADA3 IMMT LETM1 GOLGA4 | 2.79e-07 | 1487 | 81 | 16 | 33957083 | |
| Pubmed | HAUS8 DST CEP162 TAX1BP1 CEP290 RSF1 CIZ1 DIAPH1 NAV1 CHD1L GIT2 | 3.07e-07 | 645 | 81 | 11 | 25281560 | |
| Pubmed | MYH10 KCNH7 MAP1A CLU PDK1 RABEP1 SPTBN1 KTN1 NAV1 MACF1 REEP5 CIT SEPTIN6 HSP90AB1 | 3.56e-07 | 1139 | 81 | 14 | 36417873 | |
| Pubmed | TPM3 GMNC TCF4 NLRP9 BAZ2B KTN1 CEP290 ZMYM2 NCOA1 PPP1R36 GOLGA4 | 5.63e-07 | 686 | 81 | 11 | 29987050 | |
| Pubmed | TPM3 MYH10 MYH11 CCDC124 UACA SPTBN1 KTN1 TAX1BP1 ASPH RBM26 NFX1 CHD1L SEPTIN6 RSRC1 HSP90AB1 | 5.64e-07 | 1371 | 81 | 15 | 36244648 | |
| Pubmed | 6.20e-07 | 29 | 81 | 4 | 30228103 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIPOL1 TPM3 HAUS8 FAM184A MYH10 HOOK3 CEP162 CEP290 NFX1 CNTLN SEPTIN6 HSP90AB1 | 6.58e-07 | 853 | 81 | 12 | 28718761 |
| Pubmed | 1.01e-06 | 9 | 81 | 3 | 12773565 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.13e-06 | 588 | 81 | 10 | 38580884 | |
| Pubmed | MYH10 DST ATRX RBBP6 SPTBN1 TAX1BP1 DIAPH1 ZMYM2 MACF1 SMAD4 | 1.18e-06 | 591 | 81 | 10 | 15231748 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.19e-06 | 231 | 81 | 7 | 16452087 | |
| Pubmed | 1.50e-06 | 151 | 81 | 6 | 17043677 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | HAUS8 FAM184A UACA CEP162 SPTBN1 KTN1 TAX1BP1 CEP290 RSF1 CIZ1 REEP5 SMAD4 | 1.53e-06 | 925 | 81 | 12 | 28986522 |
| Pubmed | 2.03e-06 | 360 | 81 | 8 | 33111431 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MIPOL1 HAUS8 URI1 SH3GLB1 ATRX RABEP1 KTN1 CEP290 CIZ1 MIOS NAV1 GIT2 IMMT RSRC1 | 2.05e-06 | 1321 | 81 | 14 | 27173435 |
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 8424456 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | TPM3 MYH10 MYH11 DST SPTBN1 KTN1 DIAPH1 MACF1 IMMT SEPTIN6 HSP90AB1 | 2.72e-06 | 807 | 81 | 11 | 30575818 |
| Pubmed | Identification of DeltaNp63alpha protein interactions by mass spectrometry. | 4.91e-06 | 48 | 81 | 4 | 20085233 | |
| Pubmed | Overexpression of myosin is associated with the development of uterine myoma. | 5.36e-06 | 2 | 81 | 2 | 25181625 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16316347 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15265687 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11002341 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16288220 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34082069 | ||
| Pubmed | Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. | 5.36e-06 | 2 | 81 | 2 | 10906735 | |
| Pubmed | Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways. | 5.36e-06 | 2 | 81 | 2 | 12933903 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15899814 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16650383 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7916668 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15610403 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | CCDC124 RBBP6 KTN1 RBM26 GIT2 GOLGA8O IMMT RSRC1 GOLGA8N HSP90AB1 | 5.38e-06 | 701 | 81 | 10 | 30196744 |
| Pubmed | 5.85e-06 | 191 | 81 | 6 | 33762435 | ||
| Pubmed | CCDC124 DST SPTBN1 KTN1 MACF1 TMEM214 IMMT LETM1 GOLGA4 HSP90AB1 | 5.87e-06 | 708 | 81 | 10 | 39231216 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MIPOL1 MYH10 URI1 ATRX UACA RABEP1 ASPH NAV1 MACF1 CAB39L CHD1L REEP5 GOLGA4 SEPTIN6 | 8.11e-06 | 1489 | 81 | 14 | 28611215 |
| Pubmed | 9.68e-06 | 18 | 81 | 3 | 24227724 | ||
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 9.68e-06 | 18 | 81 | 3 | 11149944 | |
| Pubmed | 1.01e-05 | 122 | 81 | 5 | 29530978 | ||
| Pubmed | TPM3 MAP1A UACA CLU RBBP6 RSF1 NFRKB CIZ1 DIAPH1 TEKT1 MACF1 TADA3 | 1.03e-05 | 1116 | 81 | 12 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPM3 ATRX UACA RBBP6 SPTBN1 ASPH NFRKB ZMYM2 GOLGA4 HSP90AB1 | 1.27e-05 | 774 | 81 | 10 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPM3 MYH10 DST SPTBN1 KTN1 ASPH RSF1 DIAPH1 MACF1 CHD1L IMMT GOLGA4 HSP90AB1 | 1.41e-05 | 1353 | 81 | 13 | 29467282 |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 1.60e-05 | 3 | 81 | 2 | 12399109 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34588420 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 20184719 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16973711 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22234156 | ||
| Pubmed | Myosin, transgelin, and myosin light chain kinase: expression and function in asthma. | 1.60e-05 | 3 | 81 | 2 | 19011151 | |
| Pubmed | 1.66e-05 | 65 | 81 | 4 | 32120844 | ||
| Pubmed | 1.71e-05 | 347 | 81 | 7 | 17114649 | ||
| Pubmed | 1.82e-05 | 22 | 81 | 3 | 14627618 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.09e-05 | 358 | 81 | 7 | 32460013 | |
| Pubmed | 2.31e-05 | 503 | 81 | 8 | 36217030 | ||
| Pubmed | 2.49e-05 | 72 | 81 | 4 | 34882091 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 2.49e-05 | 147 | 81 | 5 | 28977470 | |
| Pubmed | 2.75e-05 | 251 | 81 | 6 | 27507650 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM3 PTMS CCDC124 SH3GLB1 CLU RABEP1 SPTBN1 KTN1 SPC25 NFRKB DIAPH1 MACF1 HSP90AB1 | 3.02e-05 | 1455 | 81 | 13 | 22863883 |
| Pubmed | Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis. | 3.04e-05 | 26 | 81 | 3 | 31138815 | |
| Pubmed | TPM3 MYH10 UACA CLU RBBP6 SPTBN1 KTN1 TAX1BP1 DIAPH1 CIT IMMT HSP90AB1 | 3.09e-05 | 1247 | 81 | 12 | 27684187 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 25223984 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 8954775 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 23644468 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 28751768 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 31489966 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 3.31e-05 | 156 | 81 | 5 | 30409884 | |
| Pubmed | MIPOL1 DST ATRX CLU RABEP1 SPTBN1 CEP290 ZMYM2 MACF1 CIT IMMT HSP90AB1 | 4.13e-05 | 1285 | 81 | 12 | 35914814 | |
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 4.16e-05 | 82 | 81 | 4 | 30274258 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH10 CCDC124 DST MAP1A RBBP6 PDK1 SPTBN1 MIOS ZMYM2 MACF1 HSP90AB1 | 4.16e-05 | 1082 | 81 | 11 | 38697112 |
| Pubmed | 4.17e-05 | 711 | 81 | 9 | 33022573 | ||
| Pubmed | 4.26e-05 | 29 | 81 | 3 | 28049658 | ||
| Pubmed | 4.43e-05 | 403 | 81 | 7 | 30562941 | ||
| Pubmed | 4.48e-05 | 274 | 81 | 6 | 34244482 | ||
| Pubmed | 4.72e-05 | 30 | 81 | 3 | 20301299 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 16123376 | ||
| Pubmed | A molecular network for the transport of the TI-VAMP/VAMP7 vesicles from cell center to periphery. | 5.33e-05 | 5 | 81 | 2 | 22705394 | |
| Pubmed | 5.45e-05 | 568 | 81 | 8 | 37774976 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | MIPOL1 MYH10 RBBP6 SPTBN1 KTN1 NCOA1 DEPDC7 REEP5 TADA3 HSP90AB1 | 5.60e-05 | 922 | 81 | 10 | 27609421 |
| Pubmed | 7.12e-05 | 298 | 81 | 6 | 30737378 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM3 MYH10 DST LRRIQ1 SH3GLB1 SPTBN1 RBM26 DIAPH1 MACF1 IDI1 HSP90AB1 | 7.13e-05 | 1149 | 81 | 11 | 35446349 |
| Pubmed | 7.36e-05 | 437 | 81 | 7 | 20562859 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 38644513 | ||
| Pubmed | Plasmacytoid dendritic cells control T-cell response to chronic viral infection. | 7.99e-05 | 6 | 81 | 2 | 22315415 | |
| Pubmed | URI is required to maintain intestinal architecture during ionizing radiation. | 7.99e-05 | 6 | 81 | 2 | 31147493 | |
| Interaction | MYH9 interactions | TPM3 MYH10 MYH11 CCDC124 DST MYLK UACA CEP162 SPEF2 SPTBN1 NFX1 MACF1 CIT IMMT LETM1 GOLGA4 HSP90AB1 | 5.15e-09 | 754 | 80 | 17 | int:MYH9 |
| Interaction | TRAF3IP1 interactions | 1.07e-07 | 96 | 80 | 7 | int:TRAF3IP1 | |
| Interaction | KCTD13 interactions | TPM3 CAB39 MYH10 MYH11 DST MAP1A CLU PDK1 SPTBN1 KTN1 MIOS NAV1 MACF1 PLCL1 REEP5 CIT IMMT LETM1 SEPTIN6 HSP90AB1 | 3.53e-07 | 1394 | 80 | 20 | int:KCTD13 |
| Interaction | APC interactions | MYH10 MYH11 HOOK3 DST SPTBN1 TAX1BP1 ASPH DIAPH1 NAV1 MACF1 SMAD4 | 3.83e-07 | 389 | 80 | 11 | int:APC |
| Interaction | NAA40 interactions | TPM3 MYH10 CCDC124 DST MAP1A ATRX RBBP6 RABEP1 KTN1 RSF1 RBM26 CIZ1 ZMYM2 MACF1 CIT HSP90AB1 | 1.21e-06 | 978 | 80 | 16 | int:NAA40 |
| Interaction | XRCC6 interactions | TCF4 MYH10 ATRX CLU RBBP6 PDK1 SPTBN1 WBP4 RBM26 NFX1 DIAPH1 CHD1L CIT TADA3 SMAD4 | 3.18e-06 | 928 | 80 | 15 | int:XRCC6 |
| Interaction | DCTN1 interactions | HAUS8 HOOK3 CCDC124 DST MAP1A CEP162 SPTBN1 CEP290 NAV1 MACF1 CIT | 4.15e-06 | 497 | 80 | 11 | int:DCTN1 |
| Interaction | SNAPIN interactions | 4.89e-06 | 169 | 80 | 7 | int:SNAPIN | |
| Interaction | NRIP1 interactions | 5.08e-06 | 170 | 80 | 7 | int:NRIP1 | |
| Interaction | PFN1 interactions | PTMS MAP1A RABEP1 SPTBN1 KTN1 DIAPH1 NAV1 MACF1 GIT2 GOLGA4 HSP90AB1 | 5.21e-06 | 509 | 80 | 11 | int:PFN1 |
| Interaction | MAPRE1 interactions | HOOK3 CCDC124 DST CEP162 SPTBN1 KTN1 CEP290 DIAPH1 NAV1 MACF1 HSP90AB1 | 5.71e-06 | 514 | 80 | 11 | int:MAPRE1 |
| Interaction | NUP43 interactions | DST RBBP6 BAZ2B RSF1 NFRKB RBM26 CIZ1 ZMYM2 TMEM214 CIT TADA3 HSP90AB1 | 6.25e-06 | 625 | 80 | 12 | int:NUP43 |
| Interaction | DISC1 interactions | 7.50e-06 | 429 | 80 | 10 | int:DISC1 | |
| Interaction | SMC5 interactions | CCDC124 ATRX RBBP6 BAZ2B KTN1 WBP4 RSF1 NFRKB RBM26 CIZ1 ZMYM2 POU4F3 TADA3 IMMT HSP90AB1 | 7.86e-06 | 1000 | 80 | 15 | int:SMC5 |
| Interaction | CBX3 interactions | PTMS ATRX RBBP6 TAX1BP1 RSF1 NFRKB DIAPH1 ZMYM2 MACF1 CHD1L CIT TADA3 | 8.73e-06 | 646 | 80 | 12 | int:CBX3 |
| Interaction | TRIM33 interactions | 1.20e-05 | 453 | 80 | 10 | int:TRIM33 | |
| Interaction | GOLGA8Q interactions | 1.56e-05 | 2 | 80 | 2 | int:GOLGA8Q | |
| Interaction | TRIM36 interactions | 2.33e-05 | 144 | 80 | 6 | int:TRIM36 | |
| Interaction | DSCR9 interactions | 2.62e-05 | 147 | 80 | 6 | int:DSCR9 | |
| Interaction | TRIM24 interactions | 2.81e-05 | 398 | 80 | 9 | int:TRIM24 | |
| Interaction | NEUROG3 interactions | 2.83e-05 | 149 | 80 | 6 | int:NEUROG3 | |
| Interaction | VCL interactions | 2.83e-05 | 305 | 80 | 8 | int:VCL | |
| Interaction | HERC2 interactions | 2.95e-05 | 503 | 80 | 10 | int:HERC2 | |
| Interaction | CASTOR2 interactions | 3.25e-05 | 16 | 80 | 3 | int:CASTOR2 | |
| Interaction | NDC80 interactions | 3.33e-05 | 312 | 80 | 8 | int:NDC80 | |
| Interaction | CSPP1 interactions | 4.00e-05 | 96 | 80 | 5 | int:CSPP1 | |
| Interaction | NME7 interactions | 4.22e-05 | 160 | 80 | 6 | int:NME7 | |
| Interaction | EFTUD2 interactions | TPM3 MYH10 CCDC124 SPTBN1 KTN1 WBP4 ASPH SPC25 RBM26 DIAPH1 NAV1 MACF1 CIT IMMT LETM1 GOLGA4 HSP90AB1 | 4.40e-05 | 1449 | 80 | 17 | int:EFTUD2 |
| Interaction | PSMC3 interactions | 4.68e-05 | 425 | 80 | 9 | int:PSMC3 | |
| Interaction | KTN1 interactions | 5.05e-05 | 331 | 80 | 8 | int:KTN1 | |
| Interaction | CAPZB interactions | TPM3 MYH10 MYH11 HOOK3 MYLK RBBP6 RABEP1 SPTBN1 KTN1 RSF1 NFX1 CIT IMMT HSP90AB1 | 5.94e-05 | 1049 | 80 | 14 | int:CAPZB |
| Interaction | DSCAM interactions | 6.11e-05 | 171 | 80 | 6 | int:DSCAM | |
| Interaction | H2BC9 interactions | 6.78e-05 | 446 | 80 | 9 | int:H2BC9 | |
| Interaction | TBC1D31 interactions | 7.23e-05 | 56 | 80 | 4 | int:TBC1D31 | |
| Interaction | MED4 interactions | 7.26e-05 | 450 | 80 | 9 | int:MED4 | |
| Interaction | DAXX interactions | 7.92e-05 | 353 | 80 | 8 | int:DAXX | |
| Interaction | KDM1A interactions | TPM3 TCF4 DST CLU RABEP1 CEP162 NAV1 ZMYM2 CIT TADA3 IMMT SEPTIN6 SMAD4 | 7.96e-05 | 941 | 80 | 13 | int:KDM1A |
| Interaction | YWHAH interactions | HAUS8 MYH11 DST UACA RABEP1 CEP162 SPTBN1 CEP290 NAV1 NCOA1 MACF1 GIT2 GOLGA4 HSP90AB1 | 1.01e-04 | 1102 | 80 | 14 | int:YWHAH |
| Interaction | PPP5C interactions | 1.04e-04 | 272 | 80 | 7 | int:PPP5C | |
| Interaction | IQGAP1 interactions | 1.13e-04 | 591 | 80 | 10 | int:IQGAP1 | |
| Interaction | FAM9C interactions | 1.15e-04 | 63 | 80 | 4 | int:FAM9C | |
| Interaction | NUF2 interactions | 1.30e-04 | 123 | 80 | 5 | int:NUF2 | |
| Interaction | PHIP interactions | 1.33e-04 | 197 | 80 | 6 | int:PHIP | |
| Interaction | CSK interactions | TPM3 GMNC TCF4 NLRP9 BAZ2B KTN1 CEP290 ZMYM2 NCOA1 PPP1R36 GOLGA4 HSP90AB1 | 1.42e-04 | 861 | 80 | 12 | int:CSK |
| Interaction | CBX1 interactions | 1.48e-04 | 288 | 80 | 7 | int:CBX1 | |
| Interaction | CIT interactions | TPM3 NLRP9 MYH10 MYH11 RBBP6 SPTBN1 KTN1 ASPH RSF1 MACF1 TMEM214 CIT IMMT GOLGA4 HSP90AB1 IFNL1 | 1.57e-04 | 1450 | 80 | 16 | int:CIT |
| Interaction | KCNA3 interactions | CCDC124 DST RBBP6 SPEF2 SPTBN1 KTN1 MACF1 TMEM214 IMMT LETM1 GOLGA4 HSP90AB1 | 1.58e-04 | 871 | 80 | 12 | int:KCNA3 |
| Interaction | CCDC61 interactions | 1.64e-04 | 27 | 80 | 3 | int:CCDC61 | |
| Interaction | C9orf78 interactions | HAUS8 PDK1 ASPH RBM26 DIAPH1 ZMYM2 TMEM214 IMMT LETM1 HSP90AB1 | 1.68e-04 | 620 | 80 | 10 | int:C9orf78 |
| Interaction | YWHAB interactions | PTMS URI1 HOOK3 DST UACA RABEP1 CEP162 SPTBN1 NAV1 MACF1 CNTLN REEP5 HSP90AB1 | 1.68e-04 | 1014 | 80 | 13 | int:YWHAB |
| Interaction | SNW1 interactions | ATRX RABEP1 SPTBN1 WBP4 DIAPH1 NCOA1 CHD1L DEPDC7 CIT SMAD4 HSP90AB1 | 1.72e-04 | 747 | 80 | 11 | int:SNW1 |
| Interaction | FGD5 interactions | 1.74e-04 | 207 | 80 | 6 | int:FGD5 | |
| Interaction | CALM1 interactions | 1.81e-04 | 626 | 80 | 10 | int:CALM1 | |
| Interaction | PPP1R9B interactions | MYH10 MYH11 AKAP5 MAP1A SPTBN1 NAV1 ARHGAP25 IMMT SEPTIN6 HSP90AB1 | 1.81e-04 | 626 | 80 | 10 | int:PPP1R9B |
| Interaction | MYO18A interactions | 2.01e-04 | 303 | 80 | 7 | int:MYO18A | |
| Interaction | NCKIPSD interactions | 2.16e-04 | 137 | 80 | 5 | int:NCKIPSD | |
| Interaction | NFKB1 interactions | 2.18e-04 | 307 | 80 | 7 | int:NFKB1 | |
| Interaction | PAK2 interactions | 2.20e-04 | 216 | 80 | 6 | int:PAK2 | |
| Interaction | ATF7IP interactions | 2.23e-04 | 138 | 80 | 5 | int:ATF7IP | |
| Interaction | CALR interactions | 2.36e-04 | 414 | 80 | 8 | int:CALR | |
| Interaction | KIF20A interactions | TPM3 MYH10 MYH11 UACA RBBP6 RABEP1 SPTBN1 KTN1 MACF1 REEP5 CIT IMMT HSP90AB1 | 2.41e-04 | 1052 | 80 | 13 | int:KIF20A |
| Interaction | WDFY4 interactions | 2.46e-04 | 141 | 80 | 5 | int:WDFY4 | |
| Interaction | DR1 interactions | 2.50e-04 | 77 | 80 | 4 | int:DR1 | |
| Interaction | EXOC1 interactions | 2.63e-04 | 143 | 80 | 5 | int:EXOC1 | |
| Interaction | S100A4 interactions | 2.72e-04 | 144 | 80 | 5 | int:S100A4 | |
| Interaction | GOLGA4 interactions | 2.80e-04 | 226 | 80 | 6 | int:GOLGA4 | |
| Interaction | PPP1R12A interactions | 2.92e-04 | 322 | 80 | 7 | int:PPP1R12A | |
| Interaction | AGR2 interactions | TPM3 MYH10 MYH11 DST SPTBN1 KTN1 ASPH DIAPH1 MACF1 IMMT SEPTIN6 HSP90AB1 | 3.01e-04 | 934 | 80 | 12 | int:AGR2 |
| Interaction | PLEC interactions | 3.05e-04 | 430 | 80 | 8 | int:PLEC | |
| Interaction | CAPZA2 interactions | 3.05e-04 | 430 | 80 | 8 | int:CAPZA2 | |
| Interaction | MAPRE3 interactions | 3.08e-04 | 230 | 80 | 6 | int:MAPRE3 | |
| Interaction | PCM1 interactions | 3.24e-04 | 434 | 80 | 8 | int:PCM1 | |
| Interaction | CC2D1A interactions | 3.48e-04 | 152 | 80 | 5 | int:CC2D1A | |
| Interaction | EP300 interactions | PTMS TCF4 MYH10 CIITA CLU RBBP6 WBP4 RSF1 RBM26 NCOA1 TADA3 IMMT LETM1 SEPTIN6 SMAD4 | 3.61e-04 | 1401 | 80 | 15 | int:EP300 |
| Interaction | YWHAG interactions | TPM3 HAUS8 MYH10 DST UACA RABEP1 CEP162 SPTBN1 NAV1 MACF1 GIT2 CNTLN RSRC1 HSP90AB1 | 3.65e-04 | 1248 | 80 | 14 | int:YWHAG |
| Interaction | ZBTB4 interactions | 3.91e-04 | 36 | 80 | 3 | int:ZBTB4 | |
| Interaction | PCNT interactions | 3.95e-04 | 241 | 80 | 6 | int:PCNT | |
| Interaction | CALM3 interactions | 4.26e-04 | 343 | 80 | 7 | int:CALM3 | |
| Interaction | RHOD interactions | 4.34e-04 | 572 | 80 | 9 | int:RHOD | |
| Interaction | APEX1 interactions | HAUS8 FAM184A CCDC124 UACA CEP162 SPTBN1 KTN1 TAX1BP1 CEP290 RSF1 CIZ1 CFAP74 REEP5 SMAD4 | 4.39e-04 | 1271 | 80 | 14 | int:APEX1 |
| Interaction | HAUS6 interactions | 4.54e-04 | 161 | 80 | 5 | int:HAUS6 | |
| Interaction | OFD1 interactions | 4.57e-04 | 347 | 80 | 7 | int:OFD1 | |
| Interaction | FOXO1 interactions | 4.57e-04 | 347 | 80 | 7 | int:FOXO1 | |
| Interaction | RAD18 interactions | 4.57e-04 | 457 | 80 | 8 | int:RAD18 | |
| Interaction | EXOSC9 interactions | 4.67e-04 | 162 | 80 | 5 | int:EXOSC9 | |
| Interaction | DTNBP1 interactions | 4.67e-04 | 162 | 80 | 5 | int:DTNBP1 | |
| Interaction | CTCF interactions | 4.84e-04 | 461 | 80 | 8 | int:CTCF | |
| Interaction | SGF29 interactions | 4.93e-04 | 164 | 80 | 5 | int:SGF29 | |
| Interaction | HSD17B8 interactions | 4.97e-04 | 39 | 80 | 3 | int:HSD17B8 | |
| Interaction | MYO19 interactions | 5.00e-04 | 252 | 80 | 6 | int:MYO19 | |
| Interaction | AR interactions | TPM3 TCF4 MYH10 ATRX TAX1BP1 NFRKB RBM26 ZMYM2 NCOA1 TADA3 SMAD4 HSP90AB1 | 5.18e-04 | 992 | 80 | 12 | int:AR |
| Interaction | MYL6 interactions | 5.32e-04 | 255 | 80 | 6 | int:MYL6 | |
| Interaction | FOXP1 interactions | 5.43e-04 | 256 | 80 | 6 | int:FOXP1 | |
| Interaction | HMGN1 interactions | 5.51e-04 | 168 | 80 | 5 | int:HMGN1 | |
| Interaction | FBXO42 interactions | 5.77e-04 | 259 | 80 | 6 | int:FBXO42 | |
| Interaction | BORCS6 interactions | 5.81e-04 | 170 | 80 | 5 | int:BORCS6 | |
| Interaction | EIF6 interactions | 6.17e-04 | 365 | 80 | 7 | int:EIF6 | |
| Interaction | ATG16L1 interactions | CCDC124 MAP1A RBBP6 RABEP1 KTN1 SPC25 RBM26 NAV1 KAZN GIT2 IMMT RSRC1 HSP90AB1 | 6.17e-04 | 1161 | 80 | 13 | int:ATG16L1 |
| Interaction | ASAP1 interactions | 6.27e-04 | 98 | 80 | 4 | int:ASAP1 | |
| Interaction | PIAS4 interactions | 6.29e-04 | 173 | 80 | 5 | int:PIAS4 | |
| Cytoband | 15q13.2 | 6.88e-06 | 21 | 81 | 3 | 15q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 3.10e-05 | 100 | 81 | 4 | chr15q13 | |
| Cytoband | 2q24.2 | 6.94e-04 | 22 | 81 | 2 | 2q24.2 | |
| Cytoband | 14q23.3 | 9.72e-04 | 26 | 81 | 2 | 14q23.3 | |
| Cytoband | 6q22.31 | 1.05e-03 | 27 | 81 | 2 | 6q22.31 | |
| Cytoband | 18q21.1 | 2.07e-03 | 38 | 81 | 2 | 18q21.1 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.71e-05 | 181 | 40 | 5 | 694 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.33e-04 | 8 | 40 | 2 | 939 | |
| GeneFamily | Myosin heavy chains | 4.92e-04 | 15 | 40 | 2 | 1098 | |
| GeneFamily | PHD finger proteins | 1.03e-03 | 90 | 40 | 3 | 88 | |
| GeneFamily | NLR family | 1.39e-03 | 25 | 40 | 2 | 666 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CCDC91 TCF4 MYH10 BAZ2B RABEP1 KTN1 TAX1BP1 WBP4 CEP290 RSF1 RBM26 PKIB IDI1 GOLGA4 | 1.28e-08 | 656 | 81 | 14 | M18979 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CCDC91 TCF4 URI1 SH3GLB1 ATRX RBBP6 SPTBN1 KTN1 WBP4 CEP290 NFX1 CIZ1 DIAPH1 MIOS ZMYM2 MACF1 IDI1 GOLGA4 | 2.45e-08 | 1215 | 81 | 18 | M41122 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 3.65e-07 | 90 | 81 | 6 | M39250 | |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_DN | 3.84e-07 | 48 | 81 | 5 | M19460 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 4.66e-07 | 152 | 81 | 7 | M39243 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.40e-06 | 179 | 81 | 7 | M39308 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 1.45e-06 | 260 | 81 | 8 | M41075 | |
| Coexpression | TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL | 4.49e-06 | 405 | 81 | 9 | M41667 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 5.30e-06 | 81 | 81 | 5 | M39253 | |
| Coexpression | LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA | 7.02e-06 | 322 | 81 | 8 | M39237 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 7.18e-06 | 323 | 81 | 8 | M9150 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPM3 CAB39 URI1 ATRX RBBP6 SPEF2 KTN1 RSF1 RBM26 DIAPH1 NCOA1 MACF1 ARHGAP25 GIT2 IDI1 SEPTIN6 | 1.12e-05 | 1492 | 81 | 16 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | URI1 DST ATRX BAZ2B WBP4 SPC25 ZMYM2 NCOA1 MACF1 KAZN GOLGA4 SMAD4 | 1.22e-05 | 856 | 81 | 12 | M4500 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 1.25e-05 | 165 | 81 | 6 | M8121 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS | 1.56e-05 | 101 | 81 | 5 | M43627 | |
| Coexpression | MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS | 1.64e-05 | 102 | 81 | 5 | M39259 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.86e-05 | 177 | 81 | 6 | M39245 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF4 DST MYLK MAP1A RBBP6 BAZ2B PDK1 SPTBN1 RSF1 NAV1 KAZN DEPDC7 GOLGA4 | 3.15e-05 | 1102 | 81 | 13 | M2369 |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 3.22e-05 | 398 | 81 | 8 | M14877 | |
| Coexpression | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH | 3.38e-05 | 59 | 81 | 4 | M7899 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 3.41e-05 | 523 | 81 | 9 | M12707 | |
| Coexpression | GSE27786_BCELL_VS_CD8_TCELL_UP | 3.69e-05 | 200 | 81 | 6 | M4801 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 3.69e-05 | 200 | 81 | 6 | M6056 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 3.69e-05 | 200 | 81 | 6 | M6049 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF4 DST MYLK MAP1A RBBP6 BAZ2B PDK1 SPTBN1 RSF1 NAV1 KAZN DEPDC7 GOLGA4 | 3.86e-05 | 1124 | 81 | 13 | MM1070 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 4.01e-05 | 534 | 81 | 9 | MM1054 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 4.36e-05 | 206 | 81 | 6 | M39254 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 6.75e-05 | 137 | 81 | 5 | M39241 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | MIPOL1 CCDC91 GOLGA8T ATRX CLU SPTBN1 REEP5 SEPTIN6 HSP90AB1 | 8.29e-05 | 587 | 81 | 9 | M40869 |
| Coexpression | FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL | 8.41e-05 | 232 | 81 | 6 | M41718 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | MIPOL1 HOOK3 DST UACA SPTBN1 ASPH MACF1 CAB39L IDI1 CIT RSRC1 | 9.20e-05 | 892 | 81 | 11 | M18120 |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 9.67e-05 | 238 | 81 | 6 | M12004 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 9.86e-05 | 467 | 81 | 8 | M1347 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 1.17e-04 | 154 | 81 | 5 | M6824 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.26e-04 | 484 | 81 | 8 | MM999 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.27e-04 | 250 | 81 | 6 | M11318 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 1.28e-04 | 485 | 81 | 8 | M8513 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE | 1.35e-04 | 84 | 81 | 4 | M40895 | |
| Coexpression | LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB | 2.25e-04 | 278 | 81 | 6 | M39227 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 2.36e-04 | 97 | 81 | 4 | M14698 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN | 2.37e-04 | 179 | 81 | 5 | M8928 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 2.43e-04 | 282 | 81 | 6 | MM3642 | |
| Coexpression | IBRAHIM_NRF2_UP | 2.43e-04 | 533 | 81 | 8 | M42510 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 2.49e-04 | 181 | 81 | 5 | M39225 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 2.56e-04 | 404 | 81 | 7 | M19488 | |
| Coexpression | TOMLINS_PROSTATE_CANCER_DN | 2.59e-04 | 40 | 81 | 3 | M11504 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP | 2.62e-04 | 183 | 81 | 5 | M12621 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | 2.70e-04 | 844 | 81 | 10 | M41129 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 2.78e-04 | 41 | 81 | 3 | M39320 | |
| Coexpression | GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP | 2.82e-04 | 186 | 81 | 5 | M8914 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 2.86e-04 | 102 | 81 | 4 | M2124 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 3.09e-04 | 295 | 81 | 6 | M39121 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 3.19e-04 | 191 | 81 | 5 | M40019 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 3.43e-04 | 107 | 81 | 4 | MM947 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_UP | 3.51e-04 | 195 | 81 | 5 | M4936 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP | 3.59e-04 | 196 | 81 | 5 | M4954 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 3.67e-04 | 45 | 81 | 3 | M1369 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 3.67e-04 | 45 | 81 | 3 | MM576 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DN | 3.68e-04 | 197 | 81 | 5 | M4946 | |
| Coexpression | HAY_BONE_MARROW_DENDRITIC_CELL | 3.68e-04 | 197 | 81 | 5 | M39194 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 3.68e-04 | 109 | 81 | 4 | M2451 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH2_DN | 3.76e-04 | 198 | 81 | 5 | M5425 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 3.85e-04 | 199 | 81 | 5 | M4886 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 3.85e-04 | 199 | 81 | 5 | M5159 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 3.85e-04 | 199 | 81 | 5 | M9964 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 3.90e-04 | 723 | 81 | 9 | MM3672 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 3.94e-04 | 200 | 81 | 5 | M5986 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 3.94e-04 | 200 | 81 | 5 | M5995 | |
| Coexpression | GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP | 3.94e-04 | 200 | 81 | 5 | M7053 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN | 3.94e-04 | 200 | 81 | 5 | M7296 | |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 3.94e-04 | 200 | 81 | 5 | M8541 | |
| Coexpression | GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 3.94e-04 | 200 | 81 | 5 | M8547 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 3.94e-04 | 200 | 81 | 5 | M9765 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP | 3.94e-04 | 200 | 81 | 5 | M8469 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN | 3.94e-04 | 200 | 81 | 5 | M9827 | |
| Coexpression | GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP | 3.94e-04 | 200 | 81 | 5 | M8522 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN | 4.18e-04 | 10 | 81 | 2 | MM876 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN | 4.18e-04 | 10 | 81 | 2 | M2031 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | 4.53e-04 | 317 | 81 | 6 | M40298 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_DN | 4.73e-04 | 49 | 81 | 3 | M10412 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 4.91e-04 | 322 | 81 | 6 | MM3786 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN | 4.99e-04 | 323 | 81 | 6 | M12570 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 5.14e-04 | 212 | 81 | 5 | M39221 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | LRRIQ1 MAP1A CEP162 SPEF2 SPTBN1 TAX1BP1 CEP290 DNAI2 TEKT1 CFAP74 PPP1R36 | 5.28e-04 | 1093 | 81 | 11 | M41649 |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 6.36e-04 | 126 | 81 | 4 | M39132 | |
| Coexpression | GARY_CD5_TARGETS_UP | 6.56e-04 | 473 | 81 | 7 | M17693 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 6.95e-04 | 344 | 81 | 6 | M2239 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 7.24e-04 | 481 | 81 | 7 | M3898 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | CAB39 HAUS8 TCF4 MYH10 MYH11 RABEP1 ASPH GIT2 IDI1 TADA3 RSRC1 | 7.26e-04 | 1136 | 81 | 11 | M2247 |
| Coexpression | GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 7.79e-04 | 133 | 81 | 4 | M7111 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | 7.88e-04 | 488 | 81 | 7 | M39104 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 8.38e-04 | 14 | 81 | 2 | M2576 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 8.38e-04 | 14 | 81 | 2 | MM961 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 8.57e-04 | 807 | 81 | 9 | M16651 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 8.70e-04 | 137 | 81 | 4 | MM16612 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPM3 FAM184A MYH10 URI1 HOOK3 ATRX RBBP6 RABEP1 KTN1 TAX1BP1 CEP290 RSF1 SPC25 RBM26 ZMYM2 MACF1 CFAP74 CNTLN IDI1 CIT RSRC1 HSP90AB1 | 3.60e-10 | 1257 | 77 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPM3 FAM184A MYH10 URI1 HOOK3 ATRX RBBP6 RABEP1 KTN1 TAX1BP1 CEP290 RSF1 SPC25 RBM26 ZMYM2 MACF1 CFAP74 CNTLN IDI1 CIT RSRC1 HSP90AB1 | 5.78e-09 | 1459 | 77 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | FAM184A ATRX RBBP6 RABEP1 CEP162 CEP290 ZMYM2 IDI1 CIT LETM1 GOLGA4 | 1.58e-08 | 311 | 77 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TPM3 CAB39 TCF4 DST ATRX UACA RABEP1 CEP290 RSF1 CFAP74 CAB39L CIT | 1.17e-07 | 469 | 77 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CAB39 MYH10 URI1 ATRX KTN1 TAX1BP1 CEP290 RBM26 ZMYM2 MACF1 CNTLN IDI1 CIT | 3.85e-07 | 629 | 77 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | HAUS8 MYH10 URI1 ATRX KTN1 TAX1BP1 CEP290 RBM26 DIAPH1 NAV1 ZMYM2 MACF1 CFAP74 CNTLN IDI1 CIT | 4.09e-07 | 989 | 77 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | MYH10 URI1 ATRX TAX1BP1 CEP290 RBM26 ZMYM2 MACF1 CNTLN IDI1 CIT | 4.35e-07 | 432 | 77 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | FAM184A MAP1A ATRX RBBP6 RABEP1 CEP162 KTN1 CEP290 ZMYM2 CFAP74 IDI1 CIT LETM1 GOLGA4 HSP90AB1 | 2.22e-06 | 989 | 77 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.24e-06 | 192 | 77 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FAM184A ATRX RBBP6 RABEP1 CEP162 KTN1 CEP290 ZMYM2 GIT2 IDI1 CIT LETM1 GOLGA4 | 8.33e-06 | 831 | 77 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MYLK ATRX SPTBN1 ASPH SPC25 RBM26 NAV1 GIT2 REEP5 CIT IMMT HSP90AB1 | 2.58e-05 | 790 | 77 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.30e-05 | 259 | 77 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.88e-05 | 379 | 77 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 7.83e-05 | 498 | 77 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.04e-04 | 298 | 77 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | FAM184A MAP1A ATRX RABEP1 CEP162 CEP290 ZMYM2 MACF1 CFAP74 CNTLN IDI1 CIT RSRC1 | 1.04e-04 | 1060 | 77 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | MIPOL1 MYH10 HOOK3 ATRX CEP290 RSF1 SPC25 RBM26 ZMYM2 MACF1 CNTLN IDI1 CIT RSRC1 | 1.33e-04 | 1241 | 77 | 14 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.39e-04 | 799 | 77 | 11 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | MIPOL1 MYH10 URI1 ATRX RABEP1 TAX1BP1 CEP290 ASPH RSF1 RBM26 ZMYM2 CNTLN IDI1 CIT | 1.45e-04 | 1252 | 77 | 14 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 1.72e-04 | 819 | 77 | 11 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.41e-04 | 362 | 77 | 7 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 4.11e-04 | 40 | 77 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.01e-04 | 780 | 77 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 5.09e-04 | 387 | 77 | 7 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.50e-04 | 281 | 77 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_500 | 5.52e-04 | 184 | 77 | 5 | gudmap_developingGonad_e14.5_ testes_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.89e-04 | 654 | 77 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 6.16e-04 | 801 | 77 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 6.34e-04 | 804 | 77 | 10 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.69e-04 | 192 | 77 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 6.90e-04 | 110 | 77 | 4 | gudmap_kidney_adult_Podocyte_MafB_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 6.97e-04 | 814 | 77 | 10 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500 | 7.26e-04 | 411 | 77 | 7 | gudmap_developingGonad_e14.5_ testes_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | MIPOL1 MYH10 HOOK3 ATRX CEP290 RSF1 SPC25 RBM26 ZMYM2 MACF1 CNTLN IDI1 CIT RSRC1 | 7.33e-04 | 1468 | 77 | 14 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | MYH10 ATRX CLU RABEP1 KTN1 CEP290 NCOA1 MACF1 CFAP74 CAB39L CNTLN | 7.78e-04 | 979 | 77 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TPM3 MYH10 MYH11 HOOK3 DST MYLK ATRX SPTBN1 NAV1 MACF1 GOLGA4 | 5.33e-14 | 190 | 81 | 11 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.02e-10 | 198 | 81 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.07e-10 | 199 | 81 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.12e-10 | 200 | 81 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-10 | 200 | 81 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-09 | 184 | 81 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.10e-09 | 199 | 81 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.23e-09 | 200 | 81 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.73e-08 | 190 | 81 | 7 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-08 | 191 | 81 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 6.84e-08 | 195 | 81 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 7.08e-08 | 196 | 81 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.85e-08 | 199 | 81 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.85e-08 | 199 | 81 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 18-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 7.85e-08 | 199 | 81 | 7 | d65150d2e24c40aa82712e7f034f6772102bd293 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.13e-08 | 200 | 81 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 8.13e-08 | 200 | 81 | 7 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, condition lineage and cell class | 8.13e-08 | 200 | 81 | 7 | cd381644fd8b8674a017d267bfbb00f2668294ae | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.13e-08 | 200 | 81 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.13e-08 | 200 | 81 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.10e-07 | 175 | 81 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.37e-07 | 176 | 81 | 6 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 182 | 81 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.08e-06 | 184 | 81 | 6 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 1.08e-06 | 184 | 81 | 6 | ee295f6fa898da53883e1358b17f2c2dd177e9a7 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-06 | 185 | 81 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 185 | 81 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 1.12e-06 | 185 | 81 | 6 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-06 | 186 | 81 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 1.19e-06 | 187 | 81 | 6 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-06 | 187 | 81 | 6 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-06 | 187 | 81 | 6 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.19e-06 | 187 | 81 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.19e-06 | 187 | 81 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.23e-06 | 188 | 81 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 189 | 81 | 6 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.27e-06 | 189 | 81 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 189 | 81 | 6 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 189 | 81 | 6 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.31e-06 | 190 | 81 | 6 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-06 | 190 | 81 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-06 | 190 | 81 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-06 | 190 | 81 | 6 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.31e-06 | 190 | 81 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.35e-06 | 191 | 81 | 6 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-06 | 191 | 81 | 6 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-06 | 191 | 81 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-06 | 191 | 81 | 6 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-06 | 191 | 81 | 6 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-06 | 191 | 81 | 6 | 8688708c9183ebcb200596501dc30cc12073f151 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-06 | 191 | 81 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 192 | 81 | 6 | bb7eb51bc079acacde42d8e55ba06d03eba2ea28 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 192 | 81 | 6 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-06 | 192 | 81 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-06 | 192 | 81 | 6 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 192 | 81 | 6 | a50a6279371b3be682e334082637b7ab76b9a6e5 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 192 | 81 | 6 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-06 | 194 | 81 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 194 | 81 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 1.48e-06 | 194 | 81 | 6 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.52e-06 | 195 | 81 | 6 | 7bb3bdfb8caaae357b1f7841d8d00936c4373dfe | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.52e-06 | 195 | 81 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.52e-06 | 195 | 81 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.57e-06 | 196 | 81 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.57e-06 | 196 | 81 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.57e-06 | 196 | 81 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-06 | 196 | 81 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-06 | 196 | 81 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.61e-06 | 197 | 81 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.61e-06 | 197 | 81 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.61e-06 | 197 | 81 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.61e-06 | 197 | 81 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.61e-06 | 197 | 81 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.61e-06 | 197 | 81 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 197 | 81 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.66e-06 | 198 | 81 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-06 | 198 | 81 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-06 | 198 | 81 | 6 | 08d393853e195a7eacace454153e425a273e2d23 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-06 | 198 | 81 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Transverse-(5)_Dendritic_cell-(51)_cDC1|Transverse / shred on region, Cell_type, and subtype | 1.71e-06 | 199 | 81 | 6 | 52dd1c4cd372f8ee515307a9200e357bb2145888 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.71e-06 | 199 | 81 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.71e-06 | 199 | 81 | 6 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.71e-06 | 199 | 81 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.71e-06 | 199 | 81 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.71e-06 | 199 | 81 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.71e-06 | 199 | 81 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.71e-06 | 199 | 81 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.71e-06 | 199 | 81 | 6 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.71e-06 | 199 | 81 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Transverse / Region, Cell class and subclass | 1.71e-06 | 199 | 81 | 6 | b68419939d206417158a703f60a374bf8ec5d5a1 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.71e-06 | 199 | 81 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 81 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 81 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 81 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, condition lineage and cell class | 1.76e-06 | 200 | 81 | 6 | 59cb0b0dee2599b3d3014b66d71d84c22b5de4b2 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 81 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, condition lineage and cell class | 1.76e-06 | 200 | 81 | 6 | 511e642575182fb678df6791ee6539b0ced3eb17 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 169 | 81 | 5 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.52e-05 | 171 | 81 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.51e-05 | 50 | 52 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Actin cytoskeleton binding. | 3.95e-04 | 30 | 52 | 3 | MODULE_524 | |
| Computational | Neighborhood of RFC5 | 5.33e-04 | 78 | 52 | 4 | MORF_RFC5 | |
| Computational | Genes in the cancer module 419. | 5.75e-04 | 34 | 52 | 3 | MODULE_419 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.07e-07 | 189 | 79 | 8 | 4271_DN | |
| Drug | bromfenacoum | CCDC91 CAB39 MYH10 MYH11 HOOK3 DST ATRX RABEP1 SPTBN1 MACF1 KAZN IMMT SEPTIN6 | 3.13e-07 | 644 | 79 | 13 | ctd:C013418 |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; HL60; HG-U133A | 4.20e-07 | 197 | 79 | 8 | 1371_UP | |
| Drug | Clorgyline | 1.95e-06 | 168 | 79 | 7 | ctd:D003010 | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.05e-06 | 194 | 79 | 7 | 4312_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; PC3; HT_HG-U133A | 5.59e-06 | 197 | 79 | 7 | 6694_DN | |
| Drug | phenethyl isothiocyanate | 1.03e-05 | 401 | 79 | 9 | ctd:C058305 | |
| Drug | Succimer | TCF4 SH3GLB1 MYLK ATRX CLU RBBP6 BAZ2B WBP4 ASPH RSF1 RBM26 NFX1 NAV1 IDI1 GOLGA4 | 2.54e-05 | 1264 | 79 | 15 | ctd:D004113 |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.64e-05 | 178 | 79 | 6 | 3998_DN | |
| Drug | Magnetite Nanoparticles | TCF4 SH3GLB1 MYLK ATRX CLU RBBP6 BAZ2B WBP4 ASPH RSF1 RBM26 NFX1 NAV1 IDI1 GOLGA4 | 3.84e-05 | 1310 | 79 | 15 | ctd:D058185 |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.93e-05 | 188 | 79 | 6 | 4545_DN | |
| Drug | purealin | 4.94e-05 | 58 | 79 | 4 | CID006419303 | |
| Drug | Chloroprene | TCF4 HOOK3 ATRX CIITA RBBP6 BAZ2B SPTBN1 WBP4 DNAI2 PKIB TEKT1 IDI1 PPP1R36 SEPTIN6 HSP90AB1 | 5.32e-05 | 1348 | 79 | 15 | ctd:D002737 |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | 5.71e-05 | 193 | 79 | 6 | 544_UP | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.87e-05 | 194 | 79 | 6 | 4309_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | 5.87e-05 | 194 | 79 | 6 | 1437_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HG-U133A | 6.04e-05 | 195 | 79 | 6 | 1932_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; HL60; HG-U133A | 6.04e-05 | 195 | 79 | 6 | 1582_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 6440_DN | |
| Drug | LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 1216_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 7369_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; HL60; HG-U133A | 6.22e-05 | 196 | 79 | 6 | 1716_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; HL60; HG-U133A | 6.22e-05 | 196 | 79 | 6 | 1735_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 4485_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 6890_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 5044_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 7465_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 5811_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 3484_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 5413_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; HL60; HG-U133A | 6.58e-05 | 198 | 79 | 6 | 1596_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; PC3; HG-U133A | 6.76e-05 | 199 | 79 | 6 | 1920_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A | 6.76e-05 | 199 | 79 | 6 | 1375_UP | |
| Drug | S2A | 6.77e-05 | 23 | 79 | 3 | CID016058643 | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 6.95e-05 | 200 | 79 | 6 | 5355_DN | |
| Drug | DHMP | 7.10e-05 | 4 | 79 | 2 | CID000098784 | |
| Drug | Methylnitrosourea | 1.96e-04 | 345 | 79 | 7 | ctd:D008770 | |
| Drug | geldanamycin | 3.05e-04 | 371 | 79 | 7 | ctd:C001277 | |
| Drug | limettin | 3.28e-04 | 8 | 79 | 2 | CID000002775 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.80e-04 | 177 | 79 | 5 | 985_DN | |
| Drug | AC1L9FY1 | 4.25e-04 | 101 | 79 | 4 | CID000444218 | |
| Drug | Ketone Bodies | 4.53e-04 | 522 | 79 | 8 | ctd:D007657 | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; HL60; HG-U133A | 4.54e-04 | 184 | 79 | 5 | 1772_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | 4.65e-04 | 185 | 79 | 5 | 2927_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.65e-04 | 185 | 79 | 5 | 4755_DN | |
| Drug | AG-1478; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 4.88e-04 | 187 | 79 | 5 | 1141_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.00e-04 | 188 | 79 | 5 | 6735_DN | |
| Drug | Iohexol [66108-95-0]; Down 200; 4.8uM; HL60; HT_HG-U133A | 5.00e-04 | 188 | 79 | 5 | 2461_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 5.00e-04 | 188 | 79 | 5 | 4845_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.13e-04 | 189 | 79 | 5 | 1045_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; HL60; HT_HG-U133A | 5.25e-04 | 190 | 79 | 5 | 3041_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.25e-04 | 190 | 79 | 5 | 2869_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 5.25e-04 | 190 | 79 | 5 | 4307_DN | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.25e-04 | 190 | 79 | 5 | 6719_DN | |
| Drug | thallic trifluoroacetate | 5.25e-04 | 10 | 79 | 2 | CID000090200 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A | 5.38e-04 | 191 | 79 | 5 | 1240_UP | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 5.38e-04 | 191 | 79 | 5 | 4647_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.38e-04 | 191 | 79 | 5 | 7379_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 5.38e-04 | 191 | 79 | 5 | 4269_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.38e-04 | 191 | 79 | 5 | 3926_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 5.51e-04 | 192 | 79 | 5 | 1599_DN | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; HL60; HG-U133A | 5.51e-04 | 192 | 79 | 5 | 1580_UP | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; HL60; HG-U133A | 5.51e-04 | 192 | 79 | 5 | 1778_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.64e-04 | 193 | 79 | 5 | 6716_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.64e-04 | 193 | 79 | 5 | 6331_DN | |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; PC3; HT_HG-U133A | 5.64e-04 | 193 | 79 | 5 | 6753_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 5.64e-04 | 193 | 79 | 5 | 4338_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 5.64e-04 | 193 | 79 | 5 | 6215_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 1180_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; HL60; HG-U133A | 5.77e-04 | 194 | 79 | 5 | 1409_DN | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 1307_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 1223_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 6741_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 6761_DN | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 6555_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 6066_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; HL60; HG-U133A | 5.77e-04 | 194 | 79 | 5 | 1552_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 3689_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 5.77e-04 | 194 | 79 | 5 | 2650_DN | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 449_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 5359_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; HL60; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1981_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1296_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 4646_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1514_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 6918_UP | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 5760_UP | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 7035_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; HL60; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1979_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 2359_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; HL60; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1431_DN | |
| Drug | Fillalbin [4540-25-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 4092_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; HL60; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1370_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1575_UP | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 79 | 5 | 3461_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; HL60; HG-U133A | 5.91e-04 | 195 | 79 | 5 | 1983_DN | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; HL60; HT_HG-U133A | 6.04e-04 | 196 | 79 | 5 | 3076_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 6.04e-04 | 196 | 79 | 5 | 5767_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 6.04e-04 | 196 | 79 | 5 | 2441_DN | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; HL60; HG-U133A | 6.04e-04 | 196 | 79 | 5 | 1995_UP | |
| Disease | cancer (implicated_via_orthology) | 6.04e-06 | 268 | 76 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | CCDC91 TPM3 GMNC TCF4 MYH10 LRRIQ1 BAZ2B CEP162 SPTBN1 NAV1 MACF1 PLCL1 CNTLN | 3.63e-05 | 1345 | 76 | 13 | EFO_0010736 |
| Disease | Megacystis microcolon intestinal hypoperistalsis syndrome | 3.92e-05 | 4 | 76 | 2 | C1608393 | |
| Disease | megacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in) | 6.51e-05 | 5 | 76 | 2 | DOID:0060610 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 8.59e-05 | 550 | 76 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | neuroimaging measurement | CCDC91 GMNC TCF4 MYH10 LRRIQ1 SPTBN1 KTN1 SPC25 RBM26 MACF1 PLCL1 | 8.90e-05 | 1069 | 76 | 11 | EFO_0004346 |
| Disease | grip strength measurement | 2.90e-04 | 350 | 76 | 6 | EFO_0006941 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.91e-04 | 10 | 76 | 2 | cv:C4707243 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.51e-04 | 53 | 76 | 3 | C4707243 | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 3.55e-04 | 11 | 76 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | coffee consumption measurement, major depressive disorder | 6.11e-04 | 64 | 76 | 3 | EFO_0006781, MONDO_0002009 | |
| Disease | Craniofacial Abnormalities | 7.17e-04 | 156 | 76 | 4 | C0376634 | |
| Disease | neuroimaging measurement, brain volume measurement | 8.70e-04 | 286 | 76 | 5 | EFO_0004346, EFO_0006930 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.09e-03 | 19 | 76 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | response to methotrexate, neurotoxicity | 1.09e-03 | 19 | 76 | 2 | EFO_0011057, GO_0031427 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.09e-03 | 19 | 76 | 2 | DOID:4928 (is_marker_for) | |
| Disease | pars triangularis volume measurement | 1.21e-03 | 20 | 76 | 2 | EFO_0010321 | |
| Disease | beverage consumption measurement | 1.30e-03 | 83 | 76 | 3 | EFO_0010088 | |
| Disease | Parkinson disease | 1.45e-03 | 321 | 76 | 5 | MONDO_0005180 | |
| Disease | nucleus accumbens volume | 1.46e-03 | 22 | 76 | 2 | EFO_0006931 | |
| Disease | influenza A (H1N1) | 1.49e-03 | 87 | 76 | 3 | EFO_1001488 | |
| Disease | Dysphagia | 1.74e-03 | 24 | 76 | 2 | HP_0002015 | |
| Disease | Lynch syndrome (is_implicated_in) | 1.74e-03 | 24 | 76 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | monocyte count | TCF4 CIITA BAZ2B SPEF2 SPTBN1 SPC25 DIAPH1 PKIB NCOA1 ARHGAP25 | 2.02e-03 | 1320 | 76 | 10 | EFO_0005091 |
| Disease | Visual seizure | 2.28e-03 | 101 | 76 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 2.28e-03 | 101 | 76 | 3 | C0270846 | |
| Disease | Generalized seizures | 2.28e-03 | 101 | 76 | 3 | C0234533 | |
| Disease | Clonic Seizures | 2.28e-03 | 101 | 76 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 2.28e-03 | 101 | 76 | 3 | C0422855 | |
| Disease | Gustatory seizure | 2.28e-03 | 101 | 76 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.28e-03 | 101 | 76 | 3 | C0422850 | |
| Disease | Olfactory seizure | 2.28e-03 | 101 | 76 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 2.28e-03 | 101 | 76 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.28e-03 | 101 | 76 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 2.28e-03 | 101 | 76 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 2.28e-03 | 101 | 76 | 3 | C0751496 | |
| Disease | Jacksonian Seizure | 2.28e-03 | 101 | 76 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 2.28e-03 | 101 | 76 | 3 | C0751056 | |
| Disease | Atonic Absence Seizures | 2.28e-03 | 101 | 76 | 3 | C0751123 | |
| Disease | Complex partial seizures | 2.28e-03 | 101 | 76 | 3 | C0149958 | |
| Disease | Single Seizure | 2.28e-03 | 101 | 76 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 2.28e-03 | 101 | 76 | 3 | C4317109 | |
| Disease | Nonepileptic Seizures | 2.28e-03 | 101 | 76 | 3 | C3495874 | |
| Disease | Tonic Seizures | 2.35e-03 | 102 | 76 | 3 | C0270844 | |
| Disease | Absence Seizures | 2.35e-03 | 102 | 76 | 3 | C4316903 | |
| Disease | Convulsions | 2.35e-03 | 102 | 76 | 3 | C4048158 | |
| Disease | Seizures | 2.45e-03 | 218 | 76 | 4 | C0036572 | |
| Disease | Seizures, Focal | 2.48e-03 | 104 | 76 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 2.48e-03 | 104 | 76 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.48e-03 | 104 | 76 | 3 | C0494475 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.54e-03 | 29 | 76 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELDTKDVDALLKKSE | 231 | O75528 | |
| AILEKQDKKTDKASE | 26 | Q9H9S4 | |
| SKEELEKKDLKLTLL | 1216 | Q9NXG0 | |
| KAKSLKDVEDLGKLV | 921 | P33076 | |
| KKEEAANAKLLEAEK | 971 | Q9UIF8 | |
| LEKQDISDKKAEKAT | 26 | Q9Y376 | |
| SLDLSELAKAAKKKL | 256 | Q14161 | |
| KFDKTIKAELDAAEK | 336 | Q12797 | |
| LKTLDEDSKLSAKEK | 476 | Q96QD5 | |
| KSEAKAAELEKKLDS | 476 | O60610 | |
| IFAELKKKEADAIKL | 556 | Q9GZS0 | |
| ALKEQKLKAESLSDK | 1106 | O14578 | |
| KLKAESLSDKLNDLE | 1111 | O14578 | |
| ELDLTKDSLKETKDA | 586 | Q8NB25 | |
| KKDKSEKELKALCID | 41 | Q5T8P6 | |
| AALKDKLTEAEDKIK | 196 | Q15276 | |
| ALSVKEDAKEKDEKT | 51 | Q9C010 | |
| LLDFKDKSAEDAKAI | 121 | Q15118 | |
| KAEADKNDKAVKDLV | 641 | P08238 | |
| KESKLDSLEAAAKSK | 281 | Q15746 | |
| DENLKSASKEELKKD | 1056 | Q15746 | |
| ESEDAVKALAKEKDL | 186 | Q674X7 | |
| ELAKELAKTEKKAKE | 351 | P78559 | |
| DHLKEKADLSELVKK | 461 | H3BQL2 | |
| KKIKTIKSEAEDLAE | 321 | Q6P4R8 | |
| DSDKEKTIAFLLKEL | 106 | Q8TD10 | |
| DKSLEFKKLSEELAI | 1201 | Q13439 | |
| EFLDLEKSKLKSKES | 1111 | Q9NS40 | |
| LKEKTSLADDNLKLD | 6771 | Q03001 | |
| DKKLDDDKKDIKSIT | 531 | P15884 | |
| DDSVVEKSLKSLKDK | 116 | O95202 | |
| DHLKEKADLSELVKK | 461 | H3BV12 | |
| KFSDSLKEDARKDLK | 981 | Q12986 | |
| KAVDEAADALLKAKE | 286 | Q16891 | |
| EKDKLLAAVKEDAAA | 336 | Q86UP2 | |
| SKAEDSVLLKKKLEE | 536 | Q86VS8 | |
| LDLLSELKDVTAKKD | 291 | Q9BT25 | |
| AKLKAEIEAELDKLS | 6 | Q96JM4 | |
| AAKELAENKKKIDAL | 3741 | Q9UPN3 | |
| KDKIVEKAKESLDTA | 1666 | Q7Z6E9 | |
| ALEKKDISKSEAKLS | 451 | P46100 | |
| KEELKELLKKAASGE | 176 | Q13907 | |
| AAKLEKEAVKDAVLK | 306 | Q7Z6B0 | |
| LKDLFAKADKEKLTL | 1946 | O15078 | |
| KDLDAFENETAKKVK | 296 | Q86WJ1 | |
| KKARDALEESLKLKN | 51 | Q8IU54 | |
| AEDADLSKKKAKSRL | 111 | P24588 | |
| LKDKAADAKKIQDLE | 911 | Q5TB80 | |
| DHLKEKADLSELVKK | 461 | A6NCC3 | |
| EKLEKSKKTFLDKDA | 586 | Q96T23 | |
| EAKAAADAKKQKELE | 21 | Q96CT7 | |
| SSVKELDTDADKLKK | 51 | Q9C0B2 | |
| LDTDADKLKKKTAED | 56 | Q9C0B2 | |
| TIESLEEAKKKLLKD | 1386 | P35580 | |
| EEAKKKLLKDAEALS | 1391 | P35580 | |
| KESEKKLKSLEAEIL | 1676 | P35580 | |
| REKEKAKAKAVALDS | 736 | Q8NEY1 | |
| KKLEEKEAEKKAAAS | 891 | Q9C093 | |
| ELDSLKDKLKKAQHE | 251 | Q86VP1 | |
| ANDVKSKDLLADKEL | 196 | O94763 | |
| KCLEEKAKKLLSSDE | 121 | A6NCL1 | |
| IKLELDASKKKESKD | 731 | Q15788 | |
| KLKEKKDELDSLITA | 46 | Q13485 | |
| DLDAAKTRLKKAKAA | 171 | Q9Y371 | |
| LEKDLKDKFVALTID | 171 | Q969V4 | |
| VKDLKDKAKETADAI | 156 | Q00765 | |
| SEKIAAIAEKLDLKK | 301 | Q15319 | |
| KLEDKKKSLDDEVNA | 381 | Q14141 | |
| KAFAEKLSVKLKEEE | 41 | Q9HBM1 | |
| TEDNKEKKSAKDALL | 166 | Q01082 | |
| LSNLEEAKKKKEDAL | 71 | P10909 | |
| DKAKELKSLEKEIAG | 711 | Q9ULV3 | |
| AAAKKKLEGDLKDLE | 1616 | P35749 | |
| ELKKASKEDVAKLLD | 46 | Q7RTR0 | |
| KDLEKAKLDISAIKE | 151 | Q15111 | |
| DEKVDLSKDKKLAQF | 806 | Q9NXC5 | |
| VEAAAELSAKDLKEK | 6 | P20962 | |
| LEKEKKKSAALEISL | 596 | P42331 | |
| KALDVADLQKELDKS | 116 | Q6NUQ4 | |
| SLDKAKEEEKASKEF | 51 | O75554 | |
| LTDKRLAAKDDKSAK | 91 | Q96LQ0 | |
| LAAKDDKSAKAVEKR | 96 | Q96LQ0 | |
| LEAAAKADEALKAKE | 191 | Q96IZ7 | |
| KKEISAKDEKELLHF | 1266 | Q9BZF9 | |
| DELKSSKSVKLKEDL | 1096 | Q9UBW7 | |
| KDAQEKLELAEKKAA | 66 | P06753 | |
| DHLKEKADLSELVKK | 461 | F8WBI6 |